Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China flag China · Delayed Price · Currency is CNY
9.69
+0.18 (1.89%)
Jun 1, 2026, 3:00 PM CST

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Raw Materials and Intermediates
754.04M
307.91M243.89M240.19M198.84M
Raw Materials and Intermediates Growth
-
26.25%1.54%20.79%-24.30%
Fees for Technical Services
36.83M
----
Pharmaceutical Preparation
1.89M
----
Total
792.76M
307.91M243.89M240.19M198.84M
Total Growth
-
26.25%1.54%20.79%-24.30%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
China
292.66M
Overseas
500.10M
Total
792.76M
Source: S&P Global Market Intelligence.